Literature DB >> 23956114

Local control for identifying subgroups of interest in observational research: persistence of treatment for major depressive disorder.

Douglas E Faries1, Yi Chen, Ilya Lipkovich, Anthony Zagar, Xianchen Liu, Robert L Obenchain.   

Abstract

Caregivers are regularly faced with decisions between competing treatments. Large observational health care databases provide a golden opportunity for research on heterogeneity in patient response to guide caregiver decisions, due to their sample size, diverse populations, and real-world setting. Local control is a promising tool for using observational data to detect patient subgroups with differential response on one treatment relative to another. While standard data mining approaches find subgroups with optimal responses for a particular population, detecting subgroups that reveal treatment differences while also adjusting for confounding in observational data is challenging. Local control utilizes unsupervised clustering to form non-parametric patient-level counterfactual treatment differences and displays them as an observed distribution of effect-size estimates. Classification and regression trees (CART) then find the factors that drive the greatest outcome differentiation between treatments. In this manuscript, we demonstrate the use of this two-step strategy using local control plus CART to identify depression patients most (least) likely to benefit from treatment with duloxetine relative to extended-release venlafaxine. Prior medication costs and age were found to be factors most associated with differential outcome, with prior medication costs remaining as an important factor after sensitivity analyses using a second dataset.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  classification trees; cluster analysis; counterfactual; patient heterogeneity

Mesh:

Substances:

Year:  2013        PMID: 23956114      PMCID: PMC6878447          DOI: 10.1002/mpr.1390

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  26 in total

1.  A checklist for retrospective database studies--report of the ISPOR Task Force on Retrospective Databases.

Authors:  Brenda Motheral; John Brooks; Mary Ann Clark; William H Crown; Peter Davey; Dave Hutchins; Bradley C Martin; Paul Stang
Journal:  Value Health       Date:  2003 Mar-Apr       Impact factor: 5.725

2.  Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement.

Authors:  Don C Des Jarlais; Cynthia Lyles; Nicole Crepaz
Journal:  Am J Public Health       Date:  2004-03       Impact factor: 9.308

3.  Subgroup identification from randomized clinical trial data.

Authors:  Jared C Foster; Jeremy M G Taylor; Stephen J Ruberg
Journal:  Stat Med       Date:  2011-08-04       Impact factor: 2.373

4.  Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report--Part II.

Authors:  Emily Cox; Bradley C Martin; Tjeerd Van Staa; Edeltraut Garbe; Uwe Siebert; Michael L Johnson
Journal:  Value Health       Date:  2009-09-10       Impact factor: 5.725

5.  Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part I.

Authors:  Marc L Berger; Muhammad Mamdani; David Atkins; Michael L Johnson
Journal:  Value Health       Date:  2009-09-29       Impact factor: 5.725

6.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

7.  Subgroup identification based on differential effect search--a recursive partitioning method for establishing response to treatment in patient subpopulations.

Authors:  Ilya Lipkovich; Alex Dmitrienko; Jonathan Denne; Gregory Enas
Journal:  Stat Med       Date:  2011-07-22       Impact factor: 2.373

Review 8.  Medication compliance and persistence: terminology and definitions.

Authors:  Joyce A Cramer; Anuja Roy; Anita Burrell; Carol J Fairchild; Mahesh J Fuldeore; Daniel A Ollendorf; Peter K Wong
Journal:  Value Health       Date:  2008 Jan-Feb       Impact factor: 5.725

9.  Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder.

Authors:  Xianchen Liu; Yi Chen; Douglas E Faries
Journal:  Clinicoecon Outcomes Res       Date:  2011-03-15

10.  Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.

Authors:  Craig H Mallinckrodt; John G Watkin; Chaofeng Liu; Madelaine M Wohlreich; Joel Raskin
Journal:  BMC Psychiatry       Date:  2005-01-04       Impact factor: 3.630

View more
  5 in total

1.  Identification of Clinically Meaningful Plasma Transfusion Subgroups Using Unsupervised Random Forest Clustering.

Authors:  Che Ngufor; Matthew A Warner; Dennis H Murphree; Hongfang Liu; Rickey Carter; Curtis B Storlie; Daryl J Kor
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

2.  Simple subgroup approximations to optimal treatment regimes from randomized clinical trial data.

Authors:  Jared C Foster; Jeremy M G Taylor; Niko Kaciroti; Bin Nan
Journal:  Biostatistics       Date:  2014-11-13       Impact factor: 5.899

3.  LocalControl: An R Package for Comparative Safety and Effectiveness Research.

Authors:  Nicolas R Lauve; Stuart J Nelson; S Stanley Young; Robert L Obenchain; Christophe G Lambert
Journal:  J Stat Softw       Date:  2020-11-29       Impact factor: 6.440

4.  Risk controlled decision trees and random forests for precision Medicine.

Authors:  Kevin Doubleday; Jin Zhou; Hua Zhou; Haoda Fu
Journal:  Stat Med       Date:  2021-11-16       Impact factor: 2.373

5.  Retrospective assessment of patient characteristics and healthcare costs prior to a diagnosis of Alzheimer's disease in an administrative claims database.

Authors:  Radhika Nair; Virginia S Haynes; Mir Siadaty; Nick C Patel; Adam S Fleisher; Derek Van Amerongen; Michael M Witte; AnnCatherine M Downing; Leslie Ann Hazel Fernandez; Vishal Saundankar; Daniel E Ball
Journal:  BMC Geriatr       Date:  2018-10-16       Impact factor: 3.921

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.